George Llado

George is the former Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, where he was responsible for building the company’s Global Information Technology function that enables Alexion to serve patients and their families with rare diseases. 

A bio-pharma industry veteran with over 35 years of business, information technology and cyber-security experience, George and his team developed and implemented innovative technology and data-driven insights across Alexion’s R&D, Commercial and Supply Chain functions.

Prior to joining Alexion, George served as Vice President and business line CIO for Merck and Co., where he led the large-scale merger integration of Merck/Schering-Plough across the IT and Shared Business Services organizations. George previously worked at Citibank, N.A.

George serves on the Board of Charles River Laboratories, Tracelink and The National Center for Women & Information Technology. He also serves on the senior advisory boards of Sierra Ventures and Temple University’s Fox Business School. George holds a Bachelor of Science in Computer Science from New York Institute of Technology and completed the Executive Development Program at both Harvard and Wharton School of Business.

George was awarded the NSBE Boston Lifetime Achievement Award in 2023. In 2021, he was named to Forbes CIO Next 2021 list highlighting top tech executives who are redefining the CIO role and driving innovation in their industry. In 2020, George was named a Global CIO of the Year finalist by the Boston CIO Leadership Association for demonstrating excellence in technology leadership. In 2018, he was awarded the Information Technology Leadership Award from Temple University’s Fox Business School